Recombinant human CDK5P25 (CDK5R1) (98-end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
Catalog No. C34-31G
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
C34-31G-20 | 20 ug | $215 | |
C34-31G-50 | 50 ug | $435 | |
C34-31G-BULK | BULK | Contact Us |
Overview:
CDK5P25 (cyclin-dependent kinase 5, regulatory subunit 1) is a neuron-specific activator of CDK5 and is required for proper development of the central nervous system (1). The p35 form of this protein is proteolytically cleaved by calpain, generating a p25 form of the protein which relocates from the cell periphery to nuclear and perinuclear regions. CDK5P25 regulates CDK5 activity by prolonging its activation and changing its cellular location and this may be important in pain signaling (2). The CDK5P25 accumulates in the brain neurons of patients with Alzheimer's disease and this accumulation correlates with an increase in CDK5 kinase activity which may result in aberrantly phosphorylated forms of the microtubule-associated protein tau.
Gene Aliases:
p25, CDK5R1, CDK5R, NCK5A, p23
Genbank Number:
References:
1. Tsai, L.-H.et.al: p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371: 419-423, 1994.
2. Pareek, T. K.et.al: Cyclin-dependent kinase 5 activity regulates pain signaling. Proc. Nat. Acad. Sci. 103: 791-796, 2006.
Purity:
Sample Purity Data. For specific information on a given lot, see related technical data sheet.
Storage, Stability and Shipping:
Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
~49 kDa
M Kanke et al., Cohesin acetylation and Wapl-Pds5 oppositely regulate translocation of cohesin along DNA. EMBO Journal November 2016 10.15252/embj.201695756
Miller Nimrod et al., Non-Aggregating Tau Phosphorylation by Cyclin-Dependent Kinase 5 Contributes to Motor Neuron Degeneration in Spinal Muscular Atrophy Journal of Neuroscience April 2015 10.1523/JNEUROSCI.3716-14.2015
S. Darshita B et al., Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design Journal of Molecular Graphics and Modelling July 2014 10.1016/j.jmgm.2014.06.013
Bhandaria Deepali et al., Cyclin-dependent kinase 5 activates guanine nucleotide exchange factor GIV/Girdin to orchestrate migration?proliferation dichotomy PNAS July 2015 10.1073/pnas.1514157112
Cancer, Cell Cycle, Ser/Thr Kinases
STAY CONNECTED
Fax: 1-604-232-4601